IP Library Granted Patent US 9,694,037
Granted Patent B2
US 9,694,037 · App. 12/349,392 · Granted Jul 4, 2017

Stabilized, sterilized collagen scaffolds with active adjuncts attached

Inventors: Chandrasekaran Nataraj (Gainesville, FL); Gregg Ritter (Gainesville, FL); Thomas Sander (Gainesville, FL)
Assignee: Synovis Orthopedic and Woundcare, Inc.
A61K35/32A61K35/34A61K35/36A61L17/08A61L27/3683A61F2/28A61F2/30756A61F2002/2817A61F2002/30677A61F2002/30766A61F2310/00359A61F2310/00365
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,694,037
App. No.
12/349,392
Granted
Jul 4, 2017
Kind
B2
Abstract

Bioimplants and methods of making the bioimplants are provided. The bioimplants comprise biological tissues having conjugated thereto adjunct molecules. The biological tissues are sterilized with a chemical sterilizing agent, such as a water soluble carbodiimide. The processes of making the bioimplants include a process in which an adjunct molecule is conjugated to a biological tissue during the sterilization process.

Claims (11)

1. A chemically sterilized bioimplant comprising a biological tissue and at least one protein adjunct conjugated thereto, wherein the biological tissue is processed tissue in native form and comprises crosslinked de-cellularized collagen, and wherein the bioimplant is chemically sterilized using carbodiimide.

2. The bioimplant of claim 1 , wherein the biological tissue is crosslinked with a carbodiimide.

3. The bioimplant of claim 1 , wherein the biological tissue comprises collagen, purified collagen or solubilized collagen.

4. The bioimplant of claim 1 , wherein the bioimplant is in the form of a sheet.

5. The bioimplant of claim 1 , wherein the protein adjunct retains at least some of its native activity after it has been conjugated to the biological tissue.

6. The bioimplant of claim 1 , wherein the protein adjunct is released in vivo and the adjunct, once release in vivo, possesses at least some of its native activity.

7. The biomplant of claim 1 , wherein the implant is sterilized in the presence of an alkanol.

8. The bioimplant of claim 7 , wherein the alkanol is a C 2 -C 4 alkanol.

9. The bioimplant of claim 8 , wherein the C 2 -C 4 alkanol is isopropanol.

10. The bioimplant of claim 2 , wherein the bioimplant is crosslinked in the presence of a bi-functional cross-linking agent.

11. The bioimplant of claim 1 , wherein the biological tissue is pericardium.

Assignments (7)
CHANGE OF NAME Recorded Jul 12, 2018
From: SYNOVIS ORTHOPEDIC AND WOUNDCARE, INC.
To: SYNOVIS LIFE TECHNOLOGIES, INC.
Reel/Frame 046329/0156 →
CHANGE OF NAME Recorded Aug 27, 2009
From: SYNOVIS SURGICAL SALES, INC.
To: SYNOVIS ORTHOPEDIC AND WOUNDCARE, INC.
Reel/Frame 023159/0659 →
RELEASE OF SECURITY INTEREST Recorded Aug 10, 2009
From: COMERICA BANK
To: PEGASUS BIOLOGICS, INC.
Reel/Frame 023073/0295 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 23, 2009
From: PEGASUS BIOLOGICS, INC.
To: SYNOVIS SURGICAL SALES, INC.
Reel/Frame 022999/0543 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 30, 2009
From: NATARAJ, CHANDRASEKARAN; RITTER, GREGG; SANDER, THOMAS
To: PEGASUS BIOLOGICS, INC.
Reel/Frame 022897/0487 →
SECURITY AGREEMENT Recorded Jun 5, 2009
From: PEGASUS BIOLOGICS, INC.
To: FRAZIER HEALTHCARE IV, L.P., AS AGENT
Reel/Frame 022789/0673 →
SECURITY AGREEMENT Recorded May 22, 2009
From: PEGASUS BIOLOGICS, INC.
To: COMERICA BANK
Reel/Frame 022728/0779 →
Continuity (3)
Division 11686859 · Mar 15, 2007
Provisional Application 60743542 · Mar 17, 2006
Related Publication 20090196898A1 · Aug 6, 2009